EQ net incomeQ2 2026-$4.69M
EQ net income was -$4.69M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$5.74M a year earlier. For the full fiscal 2025 it was -$22.40M, compared with -$8.07M in fiscal 2024.
Financials · EQ
Equillium Inc. (EQ) financials
For the twelve months ended Jun 30, 2026, Equillium Inc. reported -$18.01M of net income.
- Net income, TTM
- -$18.01M
- Free cash flow, TTM
- -$20.09M
- Cash
- $57.16M
- Market cap
- $117.5M
FY2022FY2024
FY2018FY2025
FY2018FY2025
EQ revenue and earnings growth
EQ EPSQ2 2026-$0.04
EQ diluted EPS was -$0.04 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$0.39.
EQ free cash flowQ2 2026-$4.18M
EQ free cash flow was -$4.18M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$3.01M a year earlier. For the full fiscal 2025 it was -$22.79M, compared with -$19.11M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | $41.09M | $36.08M | $15.76M | - | - | - | - |
| Research and development | $12.84M | $37.43M | $37.04M | $37.55M | $26.38M | $19.38M | $17.64M | $4.94M |
| Selling, general and admin | $10.79M | $11.94M | $13.57M | $17.24M | $11.41M | $10.16M | $9.09M | $3.67M |
| Operating income | -$23.63M | -$8.27M | -$14.52M | -$62.08M | -$37.79M | -$29.55M | -$26.73M | -$8.62M |
| Pre-tax income | -$22.40M | -$7.71M | -$12.76M | -$62.43M | -$39.05M | -$29.81M | -$25.60M | -$13.25M |
| Income tax | $0 | $361.0K | $580.0K | $0 | $0 | $0 | - | - |
| Net income | -$22.40M | -$8.07M | -$13.34M | -$62.43M | -$39.05M | -$29.81M | -$25.60M | -$13.25M |
| EPS, basic | -$0.39 | -$0.23 | -$0.38 | -$1.85 | -$1.36 | -$1.46 | -$1.47 | -$1.09 |
| EPS, diluted | -$0.39 | -$0.23 | -$0.38 | -$1.85 | -$1.36 | -$1.46 | -$1.47 | -$1.09 |
| Diluted shares | 57.3M | 35.4M | 34.7M | 33.7M | 28.8M | 20.4M | 17.4M | 12.2M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $30.28M | $18.09M | $23.22M | $59.11M | $50.37M | $23.98M | $13.22M | $28.51M |
| Receivables | - | $0 | $3.73M | $2.84M | $0 | - | - | - |
| Current assets | $31.04M | $24.98M | $49.35M | $76.73M | $83.37M | $85.17M | $55.43M | $67.10M |
| Total assets | $31.89M | $25.60M | $50.53M | $78.42M | $85.41M | $85.43M | $55.54M | $67.16M |
| Current liabilities | $2.93M | $6.36M | $27.57M | $32.04M | $8.91M | $7.25M | $3.88M | $2.03M |
| Short-term debt | - | - | - | $5.71M | $1.43M | $1.67M | - | - |
| Long-term debt | - | - | - | $3.24M | $8.75M | $8.28M | $9.68M | - |
| Total debt | - | - | - | $8.95M | $10.18M | $9.94M | $9.68M | - |
| Total liabilities | $3.29M | $6.54M | $27.96M | $46.48M | $18.90M | $15.57M | $13.69M | $2.23M |
| Shareholders' equity | $28.60M | $19.06M | $22.57M | $31.94M | $66.50M | $69.85M | $41.85M | $64.94M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$22.75M | -$19.03M | -$21.78M | -$8.73M | -$32.08M | -$24.62M | -$22.95M | -$7.53M |
| Capital expenditures | $48.0K | $85.0K | $50.0K | $279.0K | $57.0K | $202.0K | $74.0K | $35.0K |
| Free cash flow | -$22.79M | -$19.11M | -$21.83M | -$9.01M | -$32.14M | -$24.83M | -$23.02M | -$7.56M |
| Investing cash flow | $4.46M | $13.81M | -$4.76M | $18.68M | $27.41M | -$18.59M | -$2.17M | -$37.43M |
| Financing cash flow | $30.43M | $164.0K | -$9.23M | -$1.22M | $31.06M | $53.95M | $9.84M | $66.36M |
| Share repurchases | - | - | $260.0K | - | - | - | - | - |
| Stock-based compensation | $2.32M | $3.75M | $4.00M | $4.84M | $4.41M | $3.82M | $2.25M | $442.0K |
| Depreciation and amortization | - | - | - | $118.0K | $72.0K | $45.0K | $23.0K | $6.0K |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | 13.9% | 129.0% | - | - | - | - | - |
| Operating margin | - | -20.1% | -40.2% | -393.9% | - | - | - | - |
| Net margin | - | -19.6% | -37.0% | -396.1% | - | - | - | - |
| Free cash flow margin | - | -46.5% | -60.5% | -57.2% | - | - | - | - |
| Return on equity | -78.3% | -42.3% | -59.1% | -195.4% | -58.7% | -42.7% | -61.2% | -20.4% |
| Return on assets | -70.2% | -31.5% | -26.4% | -79.6% | -45.7% | -34.9% | -46.1% | -19.7% |
| Current ratio | 10.58 | 3.93 | 1.79 | 2.40 | 9.35 | 11.76 | 14.28 | 33.09 |
| Debt to equity | - | - | - | 0.28 | 0.15 | 0.14 | 0.23 | - |
Income statement
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | $4.39M | $12.16M | $13.85M | $10.69M | $9.21M | $8.87M |
| Research and development | $2.75M | $2.99M | $1.54M | $1.30M | $4.08M | $5.92M | $7.32M | $9.56M | $10.81M | $9.74M | $9.18M | $8.97M |
| Selling, general and admin | $2.41M | $2.62M | $2.43M | $3.27M | $2.15M | $2.95M | $1.77M | $3.28M | $3.15M | $3.74M | $3.23M | $3.52M |
| Operating income | -$5.16M | -$5.61M | -$3.96M | -$4.58M | -$6.23M | -$8.87M | -$4.70M | -$679.0K | -$100.0K | -$2.79M | -$3.20M | -$3.62M |
| Pre-tax income | - | - | - | - | - | - | - | - | - | -$2.73M | -$2.33M | -$3.21M |
| Income tax | - | - | $0 | $0 | $0 | $0 | $361.0K | $0 | $0 | $0 | $16.0K | $496.0K |
| Net income | -$4.69M | -$5.31M | -$3.77M | -$4.23M | -$5.74M | -$8.65M | -$5.79M | -$7.0K | $468.0K | -$2.73M | -$2.34M | -$3.71M |
| EPS, basic | -$0.04 | -$0.06 | - | -$0.06 | -$0.16 | -$0.24 | -$0.16 | $0.00 | $0.01 | -$0.08 | -$0.06 | -$0.11 |
| EPS, diluted | -$0.04 | -$0.06 | - | -$0.06 | -$0.16 | -$0.24 | -$0.16 | $0.00 | $0.01 | -$0.08 | -$0.06 | -$0.11 |
| Diluted shares | 111.8M | 96.3M | - | 65.3M | 35.7M | 35.6M | - | 35.4M | 36.6M | 35.3M | - | 34.9M |
Balance sheet
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $57.16M | $61.32M | $30.28M | $33.12M | $11.49M | $14.50M | $18.09M | $15.45M | $11.06M | $11.57M | $23.22M | $34.38M |
| Receivables | - | - | - | - | - | - | $0 | $5.01M | $5.89M | $5.05M | $3.73M | $3.77M |
| Current assets | $57.98M | $62.27M | $31.04M | $33.58M | $11.95M | $16.22M | $24.98M | $33.65M | $41.89M | $42.48M | $49.35M | $53.91M |
| Total assets | $58.67M | $63.08M | $31.89M | $34.51M | $12.40M | $16.73M | $25.60M | $34.46M | $42.86M | $43.60M | $50.53M | $55.23M |
| Current liabilities | $2.48M | $3.35M | $2.93M | $3.09M | $7.23M | $6.00M | $6.36M | $11.06M | $20.17M | $22.21M | $27.57M | $28.20M |
| Total liabilities | $2.65M | $3.60M | $3.29M | $3.57M | $7.34M | $6.15M | $6.54M | $11.28M | $20.43M | $22.50M | $27.96M | $31.12M |
| Shareholders' equity | $56.02M | $59.49M | $28.60M | $30.94M | $5.06M | $10.58M | $19.06M | $23.18M | $22.43M | $21.09M | $22.57M | $24.11M |
Cash flow
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.11M | -$4.30M | -$3.13M | -$8.43M | -$3.01M | -$8.17M | -$3.30M | -$7.66M | $730.0K | -$8.80M | -$5.66M | -$1.91M |
| Capital expenditures | $71.0K | $3.0K | $44.0K | $0 | $0 | $4.0K | $4.0K | $0 | $62.0K | $19.0K | $35.0K | - |
| Free cash flow | -$4.18M | -$4.30M | -$3.18M | -$8.43M | -$3.01M | -$8.17M | -$3.30M | -$7.66M | $668.0K | -$8.82M | -$5.70M | - |
| Investing cash flow | -$71.0K | -$3.0K | -$32.0K | $0 | $0 | $4.50M | $6.00M | $12.00M | -$1.35M | -$2.83M | -$5.57M | $10.98M |
| Financing cash flow | $42.0K | $35.35M | $283.0K | $30.07M | -$16.0K | $91.0K | $73.0K | $0 | - | - | $79.0K | -$260.0K |
| Share repurchases | - | - | - | - | - | - | - | - | - | - | $0 | - |
| Stock-based compensation | $1.09M | $930.0K | $737.0K | $401.0K | $563.0K | $621.0K | $821.0K | $1.00M | $952.0K | $972.0K | $1.05M | $979.0K |
| Depreciation and amortization | - | - | - | - | - | - | - | - | - | - | - | $31.0K |
Key ratios
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | - | - | - | - | - | -52.3% | 37.1% | 51.8% | 20.4% | - | - |
| Operating margin | - | - | - | - | - | - | -107.0% | -5.6% | -0.7% | -26.1% | -34.7% | -40.8% |
| Net margin | - | - | - | - | - | - | -131.9% | -0.1% | 3.4% | -25.6% | -25.4% | -41.8% |
| Free cash flow margin | - | - | - | - | - | - | -75.2% | -63.0% | 4.8% | -82.5% | -61.9% | - |
| Current ratio | 23.40 | 18.62 | 10.58 | 10.85 | 1.65 | 2.70 | 3.93 | 3.04 | 2.08 | 1.91 | 1.79 | 1.91 |
Source: XBRL data Equillium Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
EQ peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| EQ | - | - | -$18.01M | - | $117.5M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.33T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $679.13B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $518.44B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $366.73B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $312.35B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $293.69B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.40B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $183.23B |
EQ FAQ
5 questionsIs EQ profitable?
No. Equillium Inc. reported a net loss of $18.01M for the twelve months ended Jun 30, 2026.How much cash and debt does EQ have?
Equillium Inc. reported $57.16M in cash and cash equivalents on its most recent balance sheet in SEC filings.What is EQ free cash flow?
Equillium Inc. generated -$20.09M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$19.97M less capital expenditures.When did EQ last report financial results?
The latest statements here come from Equillium Inc.'s 10-Q filed on Aug 13, 2026, covering the period ended Jun 30, 2026.Where does this EQ financial data come from?
Quantisnow builds these statements from the structured XBRL data Equillium Inc. files with the SEC. It is provided for information only and is not investment advice.